Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission

Mitja Jevnikar^{1

2

3}, Olivier Sanchez^{4

5

6}, Richard Chocron^{6

7}, Marc Andronikof^{1

8}, Maurice Raphael^{1

9}, Olivier Meyrignac^{1

10}, Laure Fournier^{6

11}, David Montani^{1

2

3}, Benjamin Planquette^{4

5

6}, Mary Soudani^{1

12}, Athénaïs Boucly^{1

2

3}, Jeremie Pichon^{1

2

3}, Mariana Preda^{1

2

3}, Antoine Beurnier^{1

2

13}, Sophie Bulifon^{1

2

3}, Andrei Seferian^{1

2

3}, Xavier Jaïs^{1

2

3}, Olivier Sitbon^{1

2

3}, Laurent Savale^{1

2

3}, Marc Humbert^{1

2

3}, Florence Parent^{1

2

3}

Affiliations

¹ Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
² INSERM UMR_S 999, Le Kremlin-Bicêtre, France.
³ AP-HP, Service de Pneumologie et soins intensifs respiratoires, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
⁴ AP-HP, Service de Pneumologie et Soins Intensifs, Hôpital Européen Georges Pompidou, Paris, France.
⁵ INSERM UMR-S 1140; Paris, France and INNOVTE, St-Etienne, France.
⁶ Université Paris Descartes, Faculty of Medicine, Paris, France.
⁷ AP-HP, Service d'Urgence, Hôpital Européen Georges Pompidou, Paris, France.
⁸ AP-HP, Service d'Urgenc, Hôpital Antoine Béclère, Clamart, France.
⁹ AP-HP, Service d'Urgence, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
¹⁰ AP-HP, Service de Radiologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
¹¹ AP-HP, Service de Radiologie, Hôpital Européen Georges Pompidou, Paris, France.
¹² AP-HP, Service de gériatrie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
¹³ AP-HP, Service de physiologie et d'explorations fonctionnelles respiratoires (CRISALIS/F-CRIN network), Hôpital Bicêtre, Le Kremlin-Bicêtre, France.

PMID: 33692122
PMCID: PMC7947356
DOI: 10.1183/13993003.00116-2021

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission

Mitja Jevnikar et al. Eur Respir J. 2021.

. 2021 Jul 20;58(1):2100116.

doi: 10.1183/13993003.00116-2021. Print 2021 Jul.

Authors

Affiliations

¹ Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
² INSERM UMR_S 999, Le Kremlin-Bicêtre, France.
³ AP-HP, Service de Pneumologie et soins intensifs respiratoires, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
⁴ AP-HP, Service de Pneumologie et Soins Intensifs, Hôpital Européen Georges Pompidou, Paris, France.
⁵ INSERM UMR-S 1140; Paris, France and INNOVTE, St-Etienne, France.
⁶ Université Paris Descartes, Faculty of Medicine, Paris, France.
⁷ AP-HP, Service d'Urgence, Hôpital Européen Georges Pompidou, Paris, France.
⁸ AP-HP, Service d'Urgenc, Hôpital Antoine Béclère, Clamart, France.
⁹ AP-HP, Service d'Urgence, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
¹⁰ AP-HP, Service de Radiologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
¹¹ AP-HP, Service de Radiologie, Hôpital Européen Georges Pompidou, Paris, France.
¹² AP-HP, Service de gériatrie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
¹³ AP-HP, Service de physiologie et d'explorations fonctionnelles respiratoires (CRISALIS/F-CRIN network), Hôpital Bicêtre, Le Kremlin-Bicêtre, France.

PMID: 33692122
PMCID: PMC7947356
DOI: 10.1183/13993003.00116-2021

Abstract

There is a high prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission https://bit.ly/3reaLjv

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: M. Jevnikar has nothing to disclose. Conflict of interest: O. Sanchez has nothing to disclose. Conflict of interest: R. Chocron has nothing to disclose. Conflict of interest: M. Andronikof has nothing to disclose. Conflict of interest: M. Raphael has nothing to disclose. Conflict of interest: O. Meyrignac has nothing to disclose. Conflict of interest: L. Fournier has nothing to disclose. Conflict of interest: D. Montani has nothing to disclose. Conflict of interest: B. Planquette has nothing to disclose. Conflict of interest: M. Soudani has nothing to disclose. Conflict of interest: A. Boucly has nothing to disclose. Conflict of interest: J. Pichon has nothing to disclose. Conflict of interest: M. Preda has nothing to disclose. Conflict of interest: A. Beurnier has nothing to disclose. Conflict of interest: S. Bulifon has nothing to disclose. Conflict of interest: A. Seferian has nothing to disclose. Conflict of interest: X. Jaïs has nothing to disclose. Conflict of interest: O. Sitbon reports grants, personal fees and non-financial support from Actelion Pharmaceuticals and MSD, personal fees from Acceleron Pharmaceuticals, Gossamer Bio and Ferrer, grants and personal fees from Bayer, grants from GlaxoSmithKline, outside the submitted work. Conflict of interest: L. Savale has nothing to disclose. Conflict of interest: M. Humbert reports grants and personal fees from Actelion, personal fees from GSK and Merck, outside the submitted work. Conflict of interest: F. Parent has nothing to disclose.

Comment in

Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: is there a role for pre-test probability scores and home treatment?
Porfidia A, Pola E, Pola R. Porfidia A, et al. Eur Respir J. 2021 Aug 5;58(2):2100785. doi: 10.1183/13993003.00785-2021. Print 2021 Aug. Eur Respir J. 2021. PMID: 33833035 Free PMC article.
Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment.
Jevnikar M, Sanchez O, Humbert M, Parent F. Jevnikar M, et al. Eur Respir J. 2021 Aug 5;58(2):2101033. doi: 10.1183/13993003.01033-2021. Print 2021 Aug. Eur Respir J. 2021. PMID: 33986033 Free PMC article.

References

1. Klok FA, Kruip MJHA, van der Meer NJM, et al. . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191: 145–147. doi:10.1016/j.thromres.2020.04.013 - DOI - PMC - PubMed
1. Helms J, Tacquard C, Severac F, et al. . High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020; 46: 1089–1098. doi:10.1007/s00134-020-06062-x - DOI - PMC - PubMed
1. Frydman GH, Streiff MB, Connors JM, et al. . The potential role of coagulation factor Xa in the pathophysiology of COVID-19: a role for anticoagulants as multimodal therapeutic agents. TH Open Companion J Thromb Haemost 2020; 4: e288–e299. - PMC - PubMed
1. Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–1062. doi:10.1016/S0140-6736(20)30566-3 - DOI - PMC - PubMed
1. Xu X, Yu C, Qu J, et al. . Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging 2020; 47: 1275–1280. doi:10.1007/s00259-020-04735-9 - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission

Affiliations

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission

Authors

Affiliations

Abstract

Conflict of interest statement

Comment in

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical